Celebrex 200mg (Celecoxib)

Adult dose

The minimum recommended dose of this medicine should be adjusted according to the patient, and it may be administered with or without food. Osteoarthritis (degenerative arthritis): Take 200 mg of celecoxib once daily, or take 100 mg twice daily. Rheumatoid arthritis: Take 100 mg or 200 mg of celecoxib twice daily. Ankylosing spondylitis (AS): Administer 200 mg of celecoxib once daily, or 100 mg twice daily. If no effect is observed after 6 weeks, the dose may be increased to up to 400 mg daily. If no effect is observed after 6 weeks of taking 400 mg daily, another treatment approach should be considered. Acute pain and primary dysmenorrhea: The recommended initial dose is 400 mg of celecoxib, with an additional 200 mg on the first day of treatment if needed. From the second day of treatment, the recommended dose, if needed, is 200 mg twice daily. For patients with moderate hepatic impairment (Child-Pugh Class II), the dose should be reduced to approximately 50% of the recommended daily dose.

This drug may increase the risk of gastrointestinal bleeding when taken by individuals who consume alcohol daily, so it is essential to consult a doctor or pharmacist. It can potentially increase the risk of cardiovascular disease; thus, it should only be used at the minimum effective dose for the shortest duration, and symptoms related to the heart should be reported immediately. There is a risk of developing ulcers or gastrointestinal bleeding, so special caution is needed for individuals with a history of gastrointestinal diseases. Individuals with allergies to this medication or specific conditions (liver, kidney, heart, etc.) should not take it. Women who are pregnant, potentially pregnant, or nursing should not take this medication. Individuals with impaired liver or kidney function, hypertension, or heart failure, as well as the elderly, should use this medication carefully and require regular monitoring. This medication can interact with various drugs, so it is important to inform healthcare providers of any other medications currently being taken. Dizziness or drowsiness may occur during treatment, hence it is advisable to avoid driving or operating machinery. This medication serves as an anti-inflammatory analgesic to alleviate pain and inflammation, but routine blood tests and liver and kidney function checks should be conducted during prolonged use. In case of overdose, symptoms such as nausea, vomiting, and drowsiness may appear, and medical consultation should be sought immediately. Keep this medication out of the reach of children and do not transfer it to other containers.

Gastrointestinal bleeding, cardiovascular thromboembolic reactions, myocardial infarction, stroke, perforation of the upper and lower gastrointestinal tract, ulcers, bleeding, bronchitis, sinusitis, upper respiratory tract infections, urinary tract infections, pharyngitis, rhinitis, anemia, thrombocytopenia, hypersensitivity, insomnia, anxiety, confusion, dizziness, muscle hypertonia, drowsiness, blurred vision, tinnitus, palpitations, congestive heart failure, arrhythmia, tachycardia, hypertension, flushing, cough, vomiting, abdominal pain, diarrhea, dyspepsia, bloating, gastric ulcer, dental diseases, duodenal ulcer, esophageal ulcer, intestinal perforation, pancreatitis, elevated liver enzymes, itching, rash, urticaria, petechiae, angioedema, alopecia, bullous dermatitis, peripheral edema, facial edema, influenza-like illness, impairment, taste disturbance, albuminuria, cystitis, hematuria, dysuria, polyuria, nephrolithiasis, incontinence, visual disturbances, cataracts, conjunctivitis, eye pain, glaucoma, intraocular hemorrhage, retinal artery or vein occlusion, increased serum creatinine, positive urine hematuria, positive urine protein, renal dysfunction, acute renal failure, interstitial nephritis, increased serum sodium, increased serum potassium, increased BUN, increased CPK, diabetes mellitus, hypercholesterolemia, hyperglycemia, hypokalemia, hyperkalemia, increased NPN, increased creatinine, increased alkaline phosphatase, weight gain, loss of appetite, increased LDH, hypoglycemia, hyponatremia, bursitis, arthralgia, arthropathy, skeletal anomalies, myalgia, cervical tension syndrome, synovitis, tendinitis, myositis, leg cramps, fractures, tendon rupture, pain in various areas, muscle rigidity, decreased hematocrit, increased hemoglobin, petechiae, epistaxis, thrombocytopathy, agranulocytosis, aplastic anemia, pancytopenia, leukopenia, eosinophilic fasciitis, contact dermatitis, injection site reactions, dermal nodular lesions, headache, dizziness, constipation, thirst, ulcerative stomatitis, gastritis, allergies, low back pain, chest pain, hyperlipidemia, weight gain, fractures, arthralgia, positive RA factor, shingles, pneumonia, dyspnea, elevated ALT, hearing loss, anaphylactic reaction, hallucinations, cerebral hemorrhage, aseptic meningitis, loss of taste, loss of smell, pulmonary embolism, interstitial pneumonia, hepatitis, liver failure, fulminant hepatitis, liver necrosis, cholestasis, cholestatic hepatitis, jaundice, photosensitivity reaction, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms, acute generalized pustular rash, exfoliative dermatitis, tubular interstitial nephritis, nephrotic syndrome, minimal change disease, menstrual disorders, female infertility

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best to keep the medication at room temperature, between 15 to 30 degrees Celsius, avoiding extreme heat or cold.

Appearance

A white opaque hard capsule containing a white to off-white powder.

Package unit

30 capsules per bottle, 100 capsules per bottle